SCHEMBL5589637

SCHEMBL5589637

CCCCc1c(Cl)c(O)c(O)c(C(=O)OCl)c1CCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.39
ESR1 P03372 5/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PAK1 Q13153 1/20 0.33
TYMP P19971 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G5 P39877 1/20 0.32
HPGD P15428 3/20 0.32
KDM4E B2RXH2 3/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LDHA P00338 1/20 0.31
LDHB P07195 1/20 0.31
SIRT1 Q96EB6 1/20 0.31
PKM P14618 1/20 0.30
AKR1C2 P52895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588590 0.95 MEN1 (0.35) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5590170 0.94 PLA2G2A (0.36) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5588008 0.94 PLA2G2A (0.36) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5589225 0.94 PLA2G2A (0.36) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5589393 0.94 PLA2G2A (0.36) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5587627 0.94 PLA2G2A (0.36) FFAR1ESR1MEN1KMT2APAK1
SCHEMBL5589674 0.90 LDHA (0.36) ESR1HPGDKDM4ELDHALDHB
SCHEMBL5586638 0.87 FFAR1 (0.41) FFAR1ESR1TYMPPLA2G2APLA2G5
SCHEMBL8401470 0.84 FFAR1 (0.34) FFAR1ESR1TYMPHPGDNPC1
SCHEMBL5589042 0.83 FFAR1 (0.36) FFAR1ESR1PLA2G2APLA2G5HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 FFAR1 2521/4885ESR1 1108/4885MEN1 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.